Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Methylhydrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylhydrazine SCHEMBL8172656 | 1.00 | — | — | |
| Methylhydrazine SCHEMBL27754719 | 1.00 | — | — | |
| Methylhydrazine SCHEMBL29201448 | 0.94 | — | — | |
| Methylhydrazine SCHEMBL28087128 | 0.94 | — | — | |
| Methylhydrazine SCHEMBL3103 | 0.93 | — | — | |
| Methylhydrazine SCHEMBL3175579 | 0.93 | — | — | |
| Methylhydrazine SCHEMBL10485029 | 0.88 | — | — | |
| Methylhydrazine SCHEMBL30951729 | 0.86 | — | — | |
| Methylhydrazine SCHEMBL1472053 | 0.86 | — | — | |
| Methylhydrazine SCHEMBL631149 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119857458-A | Device and method for continuously producing methyl hydrazine by hydrazine hydrate methanol method | 河北科技大学 | 2025-04-22 | — | — | CN | claimed |
| WO-2024209278-A1 | A PROCESS FOR THE PREPARATION OF PYROXASULFONE | GHARDA CHEMICALS LIMITED (IN) | 2024-10-10 | — | — | WO | claimed |
| CN-118638029-A | Methyl hydrazine safe reduced pressure distillation process for anti-flushing material | 东力（南通）化工有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-112436089-B | Silicon resin packaged perovskite solar cell and preparation method thereof | 暨南大学 | 2023-02-07 | — | — | CN | claimed |
| WO-2022259210-A1 | NOVEL PROCESS FOR PREPARATION OF 1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-OL | INCOR RENOVIS PHARMA PRIVATE LIMITED (IN) | 2022-12-15 | — | — | WO | claimed |
| CN-109503418-B | Preparation process of methylhydrazine | 河北合佳医药科技集团股份有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-112436089-A | Silicon resin packaged perovskite solar cell and preparation method thereof | 暨南大学 | 2021-03-02 | — | — | CN | claimed |
| CN-107827820-B | Pyrazoline aminopeptidase N inhibitor and preparation method and application thereof | 山东大学 | 2020-01-07 | — | — | CN | claimed |
| CN-109503418-A | A kind of preparation process of methyl hydrazine | 河北合佳医药科技集团股份有限公司 | 2019-03-22 | — | — | CN | claimed |
| CN-109400497-A | A kind of process for cleanly preparing of methyl hydrazine | 河北合佳医药科技集团股份有限公司 | 2019-03-01 | — | — | CN | claimed |
| CN-105037196-B | The new method of catalytic synthesis of methyl hydrazine under a kind of normal pressure | 济南大学 | 2017-03-29 | — | — | CN | claimed |
| CN-105037196-A | Novel method of catalytic synthesis of methylhydrazine under normal pressure | UNIV JINAN | 2015-11-11 | — | — | CN | claimed |
| US-8957254-B2 | Process for chemical synthesis from an alkenone made from a halogenated precursor | SOLVAY SA (BE) | 2015-02-17 | — | — | US | claimed |
| US-20140051892-A1 | Process for chemical synthesis from an alkenone made from a halogenated precursor | SOLVAY SA (BE) | 2014-02-20 | — | — | US | claimed |
| CN-102516117-A | Process for producing methyl hydrazine with hydrazine hydrate method | DONGLI NANTONG CHEMICALS CO LTD | 2012-06-27 | — | — | CN | claimed |
| EP-1028116-B1 | Process for the production of taxol analogues 10-deacetyl taxol A, B, and C | COUNCIL SCIENT IND RES (IN) | 2002-10-02 | — | — | EP | claimed |
| US-6268315-B1 | Conditioning oil for bowling lanes | LANE MASTERS, INC. | 2001-07-31 | — | — | US | claimed |
| US-6028206-A | IMPROVING THE CONVERSION OF THE TAXOL ANALOGUES 7-XYLOSYL-10-DEACETYL TAXOLS A,B,C INTO THE INTERMEDIATES 10-DEACETYL TAXOLS A,B,C; ANTITUMOR AGENTS TREATING CANCER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2000-02-22 | — | — | US | claimed |
| US-4855501-A | Process for preparation of monomethylhydrazine | JAPAN HYDRAZINE CO., INC. (JP) | 1989-08-08 | — | — | US | claimed |
| JP-58157751-A | — | — | None | — | — | JP | disclosed |
| JP-57098247-A | — | — | None | — | — | JP | disclosed |
| JP-4066291-A | — | — | None | — | — | JP | disclosed |
| CN-121800681-A | Methyl hydrazine continuous flow synthesis process based on coupling of micro-channel reactor and tubular reactor | 东力（南通）化工有限公司 | 2026-04-07 | — | — | CN | disclosed |
| CN-120865090-A | Synthesis optimization process of intermediate of topiramate | 江苏优普生物化学科技股份有限公司 | 2025-10-31 | — | — | CN | disclosed |
| CN-120842127-A | Preparation method of 2-methyl thiosemicarbazide | 河北合佳医药科技集团股份有限公司 | 2025-10-28 | — | — | CN | disclosed |
| US-20250304580-A1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. (US) | 2025-10-02 | — | — | US | disclosed |
| CN-120518583-A | Preparation method of An Luoti-Ni hydrochloride intermediate | 江苏海洋大学 | 2025-08-22 | — | — | CN | disclosed |
| CN-120463614-A | Preparation method and application method of additive capable of inhibiting perovskite phase separation | 昆山晟成光电科技有限公司 | 2025-08-12 | — | — | CN | disclosed |
| EP-4587014-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | Vanqua Bio, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025106949-A1 | WRN INHIBITORS | RADD PHARMACEUTICALS, INC. (US) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025106644-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2025-05-22 | — | — | WO | disclosed |
| CN-114115143-B | Method for automatically controlling methyl hydrazine production process through DCS | 东力（南通）化工有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119857458-A | Device and method for continuously producing methyl hydrazine by hydrazine hydrate methanol method | 河北科技大学 | 2025-04-22 | — | — | CN | disclosed |
| US-20250115597-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO LTD (CN) | 2025-04-10 | — | — | US | disclosed |
| CN-119528813-A | Preparation method of 1, 3-dimethyl-5-pyrazolone | 陕西大美化工科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20250042897-A1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. (US) | 2025-02-06 | — | — | US | disclosed |
| WO-2025026270-A1 | BENZO NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2025-02-06 | — | — | WO | disclosed |
| US-20240398781-A1 | SPIROCYCLIC CYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION | CONVELO THERAPEUTICS, INC. | 2024-12-05 | — | — | US | disclosed |
| US-12129250-B2 | TYK2 inhibitors and compositions and methods thereof | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-10-29 | — | — | US | disclosed |
| WO-2024217441-A1 | GHSR 1A AGONIST, PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 长春金赛药业有限责任公司 | 2024-10-24 | — | — | WO | disclosed |
| EP-4448514-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | Lynk Pharmaceuticals Co. Ltd. (CN) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024209278-A1 | A PROCESS FOR THE PREPARATION OF PYROXASULFONE | GHARDA CHEMICALS LIMITED (IN) | 2024-10-10 | — | — | WO | disclosed |
| EP-4436975-A1 | SPIROCYCLIC CYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION | Genentech, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-118724752-A | Tyrosine kinase inhibitor intermediate, preparation method and application thereof | 重庆博腾制药科技股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118255757-B | Continuous synthesis method of pyribenzoxim | 吉林凯莱英医药化学有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118696050-A | Spirocyclic cyclic modulators of cholesterol biosynthesis and their use for promoting remyelination | 基因泰克公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118684662-A | Pyrrolopyridone-containing compounds | 正大天晴药业集团股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| EP-4430029-A1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | Vigil Neuroscience, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| CN-118638029-A | Methyl hydrazine safe reduced pressure distillation process for anti-flushing material | 东力（南通）化工有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118638029-A | Methyl hydrazine safe reduced pressure distillation process for anti-flushing material | 东力（南通）化工有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118401516-A | TYK2 inhibitors, compositions and methods thereof | 凌科药业(杭州)有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118255757-A | Continuous synthesis method of pyribenzoxim | 吉林凯莱英医药化学有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118221663-A | Continuous synthesis method of pyribenzoxim | 吉林凯莱英医药化学有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20240148732-A1 | TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS | SCHRÖDINGER, INC. | 2024-05-09 | — | — | US | disclosed |
| CN-117919755-A | Energy-saving system for methyl hydrazine concentration section by ammonia chloride method | 营口福康精细化工科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240124448-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-04-18 | — | — | US | disclosed |
| CN-117886943-A | Anti-renalase antibodies for the treatment and prevention of diseases and conditions | 耶鲁大学 | 2024-04-16 | — | — | CN | disclosed |
| WO-2024059096-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | VANQUA BIO, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-117384062-A | Continuous catalytic synthesis process of methyl hydrazine | 东力（南通）化工有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-111886257-B | Anti-renalase antibodies for the treatment and prevention of diseases and conditions | 耶鲁大学 | 2024-01-05 | — | — | CN | disclosed |
| EP-3844144-B1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ARIANEGROUP SAS (FR) | 2023-12-13 | — | — | EP | disclosed |
| EP-4284804-A1 | TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS | Schrödinger, Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-114292208-B | Method for preparing methyl hydrazine by solid acid catalysis | 杭州新本立医药有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117120442-A | Tricyclic compounds useful for treating cancer, autoimmune disorders, and inflammatory disorders | 薛定谔公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20230331707-A1 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2023-10-19 | — | — | US | disclosed |
| CN-115232023-B | Process for catalytic synthesis of methyl hydrazine | 东力（南通）化工有限公司 | 2023-08-04 | — | — | CN | disclosed |
| EP-4215532-A1 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023109954-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2023-06-22 | — | — | WO | disclosed |
| CN-116234810-A | Cell apoptosis inhibitor and preparation method and application thereof | 中国科学院上海有机化学研究所 | 2023-06-06 | — | — | CN | disclosed |
| WO-2023097233-A1 | SPIROCYCLIC CYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION | GENENTECH, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| WO-2022164789-A9 | TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS | SCHRÖDINGER, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023086800-A1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-3544972-B1 | HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS | PFIZER (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-111393404-B | Benzothiophene compounds, and pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2023-02-17 | — | — | CN | disclosed |
| CN-218290783-U | Waste salt processing system in methylhydrazine processing | 东力（南通）化工有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| WO-2022259210-A1 | NOVEL PROCESS FOR PREPARATION OF 1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-OL | INCOR RENOVIS PHARMA PRIVATE LIMITED (IN) | 2022-12-15 | — | — | WO | disclosed |
| CN-115381818-A | Method for promoting autophagy degradation function of cells and application | 大理大学 | 2022-11-25 | — | — | CN | disclosed |
| CN-115232023-A | Novel process for catalytically synthesizing methylhydrazine | 东力（南通）化工有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-110234638-B | Heteroaryl phenoxy benzamide KAPPA opioid ligands | 辉瑞大药厂 | 2022-10-21 | — | — | CN | disclosed |
| CN-115141146-A | Synthesis method of hypoglycemic active compound 1,2, 3-trimethyl-4- (p-chlorophenyl) -pyrazolium salt | 东力（南通）化工有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-20220274970-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2022-09-01 | — | — | US | disclosed |
| WO-2022164789-A1 | TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISODERS | SCHRÖDINGER, INC. (US) | 2022-08-04 | — | — | WO | disclosed |
| EP-4003986-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2022-06-01 | — | — | EP | disclosed |
| CN-114450281-A | Inhibitor compounds | 辛塞拉治疗私人有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114292208-A | Method for preparing methylhydrazine by solid acid catalysis | 杭州新本立医药有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114262322-A | Apoptosis inhibitor and preparation method and application thereof | 中国科学院上海有机化学研究所 | 2022-04-01 | — | — | CN | disclosed |
| WO-2022057787-A1 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国科学院上海有机化学研究所 | 2022-03-24 | — | — | WO | disclosed |
| EP-3971191-A1 | BORON-CONTAINING SMALL MOLECULES | Bill And Melinda Gates Foundation (US) | 2022-03-23 | — | — | EP | disclosed |
| CN-114133339-A | Methyl hydrazine continuous flow microchannel alkylation method | 东力（南通）化工有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-113955727-A | Method for treating redundant waste salt in methyl hydrazine production process | 东力（南通）化工有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113666347-A | Regeneration treatment method of hydrazine hydrate hydrochloride | 陕西大美化工科技有限公司 | 2021-11-19 | — | — | CN | disclosed |
| CN-113563368-A | Boron-containing small molecules | 比尔及梅琳达盖茨基金会 | 2021-10-29 | — | — | CN | disclosed |
| CN-113363390-A | High-efficiency perovskite solar cell and preparation method | 南开大学 | 2021-09-07 | — | — | CN | disclosed |
| CN-113321672-A | Boron-containing small molecules | 比尔及梅琳达盖茨基金会 | 2021-08-31 | — | — | CN | disclosed |
| EP-3423065-B1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS INC (US) | 2021-07-21 | — | — | EP | disclosed |
| EP-3844144-A1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ArianeGroup SAS (FR) | 2021-07-07 | — | — | EP | disclosed |
| CN-109503418-B | Preparation process of methylhydrazine | 河北合佳医药科技集团股份有限公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-109503418-B | Preparation process of methylhydrazine | 河北合佳医药科技集团股份有限公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-109195608-B | Boron-containing small molecules | 比尔及梅琳达盖茨基金会 | 2021-05-11 | — | — | CN | disclosed |
| US-10919916-B2 | Boron-containing small molecules | BILL & MELINDA GATES FOUNDATION (US) | 2021-02-16 | — | — | US | disclosed |
| CN-107709323-B | Hydroxyl purine compound and application thereof | 广东众生睿创生物科技有限公司 | 2020-11-20 | — | — | CN | disclosed |
| US-20200247827-A1 | BORON-CONTAINING SMALL MOLECULES | BILL & MELINDA GATES FOUNDATION (US) | 2020-08-06 | — | — | US | disclosed |
| CN-111393404-A | Benzothiophene compounds, and pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2020-07-10 | — | — | CN | disclosed |
| CN-111320554-A | Improved technology of monomethylhydrazine production process | 东力（南通）化工有限公司 | 2020-06-23 | — | — | CN | disclosed |
| US-10611780-B2 | Boron-containing small molecules | BILL AND MELINDA GATES FOUNDATION (US) | 2020-04-07 | — | — | US | disclosed |
| EP-2631255-B1 | FILLER COMPOSITION FOR SPACE BETWEEN LAYERS OF THREE-DIMENSIONAL INTEGRATED CIRCUIT, COATING FLUID, AND PROCESS FOR PRODUCING THREE-DIMENSIONAL INTEGRATED CIRCUIT | MITSUBISHI CHEM CORP (JP) | 2020-03-18 | — | — | EP | disclosed |
| WO-2020043997-A1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ARIANEGROUP SAS (FR) | 2020-03-05 | — | — | WO | disclosed |
| EP-3544972-A1 | HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS | Pfizer Inc (US) | 2019-10-02 | — | — | EP | disclosed |
| WO-2019175511-A1 | PRODUCTION OF BIS-HYDRAZINES | ARIANEGROUP SAS (FR) | 2019-09-19 | — | — | WO | disclosed |
| CN-110234638-A | Heteroaryl phenoxy benzamide KAPPA opiates ligand | 辉瑞大药厂 | 2019-09-13 | — | — | CN | disclosed |
| US-10400151-B2 | Agglomerated boron nitride particles, composition containing said particles, and three- dimensional integrated circuit having layer comprising said composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-09-03 | — | — | US | disclosed |
| US-10316021-B2 | Heteroarylphenoxy benzamide kappa opioid ligands | PFIZER INC. (US) | 2019-06-11 | — | — | US | disclosed |
| US-10278973-B2 | Hydroxyl purine compounds and use thereof | Guangdong Raynovent Biotech Co., Ltd. (CN) | 2019-05-07 | — | — | US | disclosed |
| CN-109503418-A | A kind of preparation process of methyl hydrazine | 河北合佳医药科技集团股份有限公司 | 2019-03-22 | — | — | CN | disclosed |
| US-20190077814-A1 | BORON-CONTAINING SMALL MOLECULES | GATES FOUNDATION | 2019-03-14 | — | — | US | disclosed |
| US-10227545-B2 | Additives for oilfield and industrial applications | EMERY OLEOCHEMICALS GMBH (DE) | 2019-03-12 | — | — | US | disclosed |
| CN-109400497-A | A kind of process for cleanly preparing of methyl hydrazine | 河北合佳医药科技集团股份有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-109400497-A | A kind of process for cleanly preparing of methyl hydrazine | 河北合佳医药科技集团股份有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-109195608-A | Boron-containing small molecules | 比尔及梅琳达盖茨基金会 | 2019-01-11 | — | — | CN | disclosed |
| EP-3423065-A1 | BORON-CONTAINING SMALL MOLECULES | Anacor Pharmaceuticals, Inc. (US) | 2019-01-09 | — | — | EP | disclosed |
| CN-105947997-B | Boron nitride agglomerated particles, composition containing the same, and three-dimensional integrated circuit having layer containing the composition | 三菱化学株式会社 | 2018-12-21 | — | — | CN | disclosed |
| EP-3242920-B1 | NEW ADDITIVES FOR OILFIELD AND INDUSTRIAL APPLICATIONS | EMERY OLEOCHEMICALS GMBH (DE) | 2018-12-19 | — | — | EP | disclosed |
| US-10125289-B2 | Composition for interlayer filler of layered semiconductor device, layered semiconductor device, and process for producing layered semiconductor device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-11-13 | — | — | US | disclosed |
| US-20180311635-A1 | METHOD FOR IMMOBILISING A COMPOUND OF INTEREST ON A SUBSTRATE IN A GIVEN PATTERN AND KIT FOR IMPLEMENTING SAME | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-11-01 | — | — | US | disclosed |
| EP-1646095-B2 | Stabilised silver nanoparticles and their use | XEROX CORP (US) | 2018-10-17 | — | — | EP | disclosed |
| CN-106044727-B | Boron nitride agglomerated particles, composition containing the same, and three-dimensional integrated circuit having layer containing the composition | 三菱化学株式会社 | 2018-09-25 | — | — | CN | disclosed |
| EP-3368899-A1 | METHOD FOR IMMOBILISING A COMPOUND OF INTEREST ON A SUBSTRATE IN A GIVEN PATTERN AND KIT FOR IMPLEMENTING SAME | Dendris (FR) | 2018-09-05 | — | — | EP | disclosed |
| CN-108337902-A | Method for fixing a compound of interest on a substrate in a given pattern and kit for carrying out said method | 登得利斯公司 | 2018-07-27 | — | — | CN | disclosed |
| WO-2018096510-A1 | HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS | PFIZER INC. (US) | 2018-05-31 | — | — | WO | disclosed |
| US-20180148432-A1 | HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS | PFIZER INC. (US) | 2018-05-31 | — | — | US | disclosed |
| US-20180140607-A1 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | Guangdong Raynovent Biotech Co., Ltd. (CN) | 2018-05-24 | — | — | US | disclosed |
| US-9960092-B2 | Interlayer filler composition for three-dimensional integrated circuit | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-05-01 | — | — | US | disclosed |
| CN-105073883-B | Composition for interlayer filling material of laminated semiconductor device, and method for manufacturing laminated semiconductor device | 三菱化学株式会社 | 2018-04-17 | — | — | CN | disclosed |
| EP-3299371-A1 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) | 2018-03-28 | — | — | EP | disclosed |
| CN-107709323-A | Oxipurinol class compound and its application | 广东众生药业股份有限公司 | 2018-02-16 | — | — | CN | disclosed |
| CN-107641114-A | Compound and its application as isocitric dehydrogenase inhibitor | 南京圣和药业股份有限公司 | 2018-01-30 | — | — | CN | disclosed |
| CN-105873928-B | 5 hydroxyl 4 (trifluoromethyl) pyrazolo pyridine derivatives | 第三共株式会社 | 2018-01-23 | — | — | CN | disclosed |
| EP-3269682-A1 | AGGLOMERATED BORON NITRIDE PARTICLES, COMPOSITION CONTAINING SAID PARTICLES, AND THREE-DIMENSIONAL INTEGRATED CIRCUIT HAVING LAYER COMPRISING SAID COMPOSITION | Mitsubishi Chemical Corporation (JP) | 2018-01-17 | — | — | EP | disclosed |
| CN-106543026-B | A kind of preparation method of methyl hydrazine | 石家庄金派医药化工有限公司 | 2018-01-16 | — | — | CN | disclosed |
| US-9847298-B2 | Three-dimensional integrated circuit laminate, and interlayer filler for three-dimensional integrated circuit laminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-12-19 | — | — | US | disclosed |
| US-20170342341-A1 | NEW ADDITIVES FOR OILFIELD AND INDUSTRIAL APPLICATIONS | BANK OF AMERICA, N.A., AS THE ADMINISTRATIVE AGENT | 2017-11-30 | — | — | US | disclosed |
| US-20170335160-A1 | AGGLOMERATED BORON NITRIDE PARTICLES, COMPOSITION CONTAINING SAID PARTICLES, AND THREE-DIMENSIONAL INTEGRATED CIRCUIT HAVING LAYER COMPRISING SAID COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-11-23 | — | — | US | disclosed |
| US-9822294-B2 | Agglomerated boron nitride particles, composition containing said particles, and three-dimensional integrated circuit having layer comprising said composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| EP-3242920-A1 | NEW ADDITIVES FOR OILFIELD AND INDUSTRIAL APPLICATIONS | Emery Oleochemicals GmbH (DE) | 2017-11-15 | — | — | EP | disclosed |
| US-9783722-B2 | — | — | 2017-10-10 | — | — | US | disclosed |
| US-20170287866-A1 | INTERLAYER FILLER COMPOSITION FOR SEMICONDUCTOR DEVICE AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| EP-2786961-B1 | AGGREGATED BORON NITRIDE PARTICLES, COMPOSITION CONTAINING SAID PARTICLES, AND THREE-DIMENSIONAL INTEGRATED CIRCUIT HAVING LAYER COMPRISING SAID COMPOSITION | MITSUBISHI CHEM CORP (JP) | 2017-09-13 | — | — | EP | disclosed |
| CN-104744491-B | Benzo oxazepine * PI3K inhibitor compounds and application method | 霍夫曼-拉罗奇有限公司 | 2017-07-11 | — | — | CN | disclosed |
| CN-106928247-A | Spiral shell oxindole compounds and its purposes as therapeutic agent | 泽农医药公司 | 2017-07-07 | — | — | CN | disclosed |
| EP-2822953-B9 | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | PFIZER (US) | 2017-06-21 | — | — | EP | disclosed |
| US-9670228-B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| CN-106784318-A | Methylamino halide CNT semiconductor light dependent sensor and preparation method | 同济大学 | 2017-05-31 | — | — | CN | disclosed |
| CN-102256983-B | Spirooxindole compounds and their use as therapeutic agents | 泽农医药公司 | 2017-04-05 | — | — | CN | disclosed |
| CN-106543026-A | A kind of preparation method of methyl hydrazine | 重庆锦杉科技有限公司 | 2017-03-29 | — | — | CN | disclosed |
| US-20170081341-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2017-03-23 | — | — | US | disclosed |
| US-20170033050-A1 | THREE-DIMENSIONAL INTEGRATED CIRCUIT LAMINATE, AND INTERLAYER FILLER FOR THREE-DIMENSIONAL INTEGRATED CIRCUIT LAMINATE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
| EP-2822953-B1 | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | PFIZER (US) | 2017-02-01 | — | — | EP | disclosed |
| US-9546178-B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2017-01-17 | — | — | US | disclosed |
| US-9508648-B2 | Three-dimensional integrated circuit laminate, and interlayer filler for three-dimensional integrated circuit laminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| CN-105873928-A | 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative | 第三共株式会社 | 2016-08-17 | — | — | CN | disclosed |
| WO-2016110322-A1 | NEW ADDITIVES FOR OILFIELD AND INDUSTRIAL APPLICATIONS | AMRIL AG (CH) | 2016-07-14 | — | — | WO | disclosed |
| US-20160159773-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-06-09 | — | — | US | disclosed |
| EP-3029031-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2016-06-08 | — | — | EP | disclosed |
| CN-104169286-B | Be used for the treatment of the macrocyclic derivatives of proliferative diseases | 辉瑞大药厂 | 2016-06-08 | — | — | CN | disclosed |
| WO-2016051193-A1 | COMPOUNDS USEFUL AS CSF1 MODULATORS | REDX PHARMA PLC (GB) | 2016-04-07 | — | — | WO | disclosed |
| EP-1646095-B1 | Stabilised silver nanoparticles and their use | XEROX CORP (US) | 2016-03-09 | — | — | EP | disclosed |
| US-20160052933-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2016-02-25 | — | — | US | disclosed |
| CN-102516117-B | The technique of producing methyl hydrazine with hydrazine hydrate method | DONGLI (NANTONG) CHEMICALS CO., LTD. (CN) | 2016-01-20 | — | — | CN | disclosed |
| CN-102516117-B | The technique of producing methyl hydrazine with hydrazine hydrate method | DONGLI (NANTONG) CHEMICALS CO., LTD. (CN) | 2016-01-20 | — | — | CN | disclosed |
| US-20160009947-A1 | COMPOSITION FOR INTERLAYER FILLER OF LAYERED SEMICONDUCTOR DEVICE, LAYERED SEMICONDUCTOR DEVICE, AND PROCESS FOR PRODUCING LAYERED SEMICONDUCTOR DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9227273-B2 | Pb-free solder paste | SUMITOMO METAL MINING CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-9198918-B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| CN-105073883-A | Composition for interlayer filling material of laminated semiconductor device, and method for manufacturing laminated semiconductor device | MITSUBISHI CHEM CORP | 2015-11-18 | — | — | CN | disclosed |
| CN-105037196-A | Novel method of catalytic synthesis of methylhydrazine under normal pressure | UNIV JINAN | 2015-11-11 | — | — | CN | disclosed |
| CN-105037196-A | Novel method of catalytic synthesis of methylhydrazine under normal pressure | UNIV JINAN | 2015-11-11 | — | — | CN | disclosed |
| EP-2421871-B1 | THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER | BOEHRINGER INGELHEIM INT (DE) | 2015-09-16 | — | — | EP | disclosed |
| US-9133215-B2 | Macrocyclic derivatives for the treatment of diseases | PFIZER INC. (US) | 2015-09-15 | — | — | US | disclosed |
| CN-104744491-A | Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use | HOFFMAN LA ROCHE AG | 2015-07-01 | — | — | CN | disclosed |
| EP-2350084-B1 | TETRA-AZA-HETEROCYCLES AS PHOSPHATIDYLINOSITOL-3-KINASES (PI3-KINASES) INHIBITOR | BOEHRINGER INGELHEIM INT (DE) | 2015-06-24 | — | — | EP | disclosed |
| CN-102762576-B | Benzoxazepine PI3K inhibitor compounds and methods of use | HOFFMANN LA ROCHE | 2015-04-22 | — | — | CN | disclosed |
| CN-102087892-B | Ultra low melt metal nanoparticle composition and method of forming conductive features by using the same | XEROX CORP | 2015-04-08 | — | — | CN | disclosed |
| CN-103561902-B | Pb-free solder paste | SUMITOMO METAL MINING CO | 2015-04-01 | — | — | CN | disclosed |
| EP-2845592-A1 | Benzoxazepin PI3K inhibitor compounds and methods of use | F. Hoffmann-La Roche AG (CH) | 2015-03-11 | — | — | EP | disclosed |
| US-8957254-B2 | Process for chemical synthesis from an alkenone made from a halogenated precursor | SOLVAY SA (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8940197-B2 | Processes for producing palladium nanoparticle inks | XEROX CORPORATION (US) | 2015-01-27 | — | — | US | disclosed |
| EP-2822953-A1 | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | Pfizer Inc. (US) | 2015-01-14 | — | — | EP | disclosed |
| US-20140377457-A1 | METHOD OF FORMING METAL NANOPARTICLE DISPERSION AND DISPERSION FORMED THEREBY | XEROX CORPORATION | 2014-12-25 | — | — | US | disclosed |
| US-20140349105-A1 | AGGLOMERATED BORON NITRIDE PARTICLES, COMPOSITION CONTAINING SAID PARTICLES, AND THREE-DIMENSIONAL INTEGRATED CIRCUIT HAVING LAYER COMPRISING SAID COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-27 | — | — | US | disclosed |
| CN-104169286-A | Macrocyclic derivatives for the treatment of proliferative diseases | PFIZER | 2014-11-26 | — | — | CN | disclosed |
| EP-2786961-A1 | AGGREGATED BORON NITRIDE PARTICLES, COMPOSITION CONTAINING SAID PARTICLES, AND THREE-DIMENSIONAL INTEGRATED CIRCUIT HAVING LAYER COMPRISING SAID COMPOSITION | Mitsubishi Chemical Corporation (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-20140288047-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2014-09-25 | — | — | US | disclosed |
| CN-103958400-A | Boron nitride agglomerated particles, composition containing the same, and three-dimensional integrated circuit having layer containing the composition | MITSUBISHI CHEM CORP | 2014-07-30 | — | — | CN | disclosed |
| US-8785626-B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2014-07-22 | — | — | US | disclosed |
| CN-101643201-B | Silver nanoparticle process | XEROX CORP | 2014-05-28 | — | — | CN | disclosed |
| US-20140135339-A1 | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES | PFIZER INC. (US) | 2014-05-15 | — | — | US | disclosed |
| EP-2711368-A1 | Benzoxazepin PI3K inhibitor compounds and methods of use | F. Hoffmann-La Roche AG (CH) | 2014-03-26 | — | — | EP | disclosed |
| US-8680111-B2 | Macrocyclic derivatives for the treatment of diseases | PFIZER INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20140058098-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2014-02-27 | — | — | US | disclosed |
| US-20140051892-A1 | Process for chemical synthesis from an alkenone made from a halogenated precursor | SOLVAY SA (BE) | 2014-02-20 | — | — | US | disclosed |
| US-8653097-B2 | Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-02-18 | — | — | US | disclosed |
| US-20140041760-A1 | Pb-FREE SOLDER PASTE | SUMITOMO METAL MINING CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| EP-2693476-A1 | THREE-DIMENSIONAL INTEGRATED CIRCUIT LAMINATE AND INTERLAYER FILLER MATERIAL FOR THREE-DIMENSIONAL INTEGRATED CIRCUIT LAMINATE | Mitsubishi Chemical Corporation (JP) | 2014-02-05 | — | — | EP | disclosed |
| CN-103561902-A | Pb-free solder paste | SUMITOMO METAL MINING CO | 2014-02-05 | — | — | CN | disclosed |
| US-20140030848-A1 | INTERLAYER FILLER COMPOSITION FOR THREE-DIMENSIONAL INTEGRATED CIRCUIT, COATING FLUID AND PROCESS FOR PRODUCING THREE-DIMENSIONAL INTEGRATED CIRCUIT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-01-30 | — | — | US | disclosed |
| US-20140027885-A1 | THREE-DIMENSIONAL INTEGRATED CIRCUIT LAMINATE, AND INTERLAYER FILLER FOR THREE-DIMENSIONAL INTEGRATED CIRCUIT LAMINATE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-01-30 | — | — | US | disclosed |
| EP-2483278-B1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | HOFFMANN LA ROCHE (CH) | 2013-12-25 | — | — | EP | disclosed |
| CN-103443919-A | Three-dimensional integrated circuit laminate and interlayer filling material for three-dimensional integrated circuit laminate | MITSUBISHI CHEM CORP | 2013-12-11 | — | — | CN | disclosed |
| US-8586574-B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-8546404-B2 | Compounds that are ERK inhibitors | MERCK SHARP & DOHME (US) | 2013-10-01 | — | — | US | disclosed |
| US-20130252961-A1 | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES | PFIZER INC. (US) | 2013-09-26 | — | — | US | disclosed |
| WO-2013132376-A1 | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | PFIZER INC. (US) | 2013-09-12 | — | — | WO | disclosed |
| EP-2161087-B1 | Silver nanoparticle process | XEROX CORP (US) | 2013-09-11 | — | — | EP | disclosed |
| US-20130221288-A1 | PROCESSES FOR PRODUCING PALLADIUM NANOPARTICLE INKS | XEROX CORPORATION (US) | 2013-08-29 | — | — | US | disclosed |
| EP-2042483-B1 | Method for manufacturing monomethyl hydrazine | SALTIGO GMBH (DE) | 2013-08-28 | — | — | EP | disclosed |
| EP-2631255-A1 | FILLER COMPOSITION FOR SPACE BETWEEN LAYERS OF THREE-DIMENSIONAL INTEGRATED CIRCUIT, COATING FLUID, AND PROCESS FOR PRODUCING THREE-DIMENSIONAL INTEGRATED CIRCUIT | Mitsubishi Chemical Corporation (JP) | 2013-08-28 | — | — | EP | disclosed |
| EP-2155722-B1 | POLYCYCLIC INDAZOLE DERIVATIVES AND THEIR USE AS ERK INHIBITORS FOR THE TREATMENT OF CANCER | MERCK SHARP & DOHME (US) | 2013-08-14 | — | — | EP | disclosed |
| CN-103154070-A | Interlayer filler composition for three-dimensional integrated circuit, coating liquid, and method for producing three-dimensional integrated circuit | MITSUBISHI CHEM CORP | 2013-06-12 | — | — | CN | disclosed |
| US-20130079331-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| CN-101397264-B | Method for manufacturing monomethyl hydrazine | SALTIGO GMBH | 2013-03-27 | — | — | CN | disclosed |
| US-8382878-B2 | Silver nanoparticle process | XEROX CORPORATION (US) | 2013-02-26 | — | — | US | disclosed |
| US-8367027-B2 | Regeneration of ammonia borane from polyborazylene | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2013-02-05 | — | — | US | disclosed |
| US-8343955-B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| CN-202569753-U | Filtering detection device | DONGLI NANTONG CHEMICALS CO LTD | 2012-12-05 | — | — | CN | disclosed |
| CN-102762576-A | Benzoxazepine PI3K inhibitor compounds and methods of use | HOFFMANN LA ROCHE | 2012-10-31 | — | — | CN | disclosed |
| US-20120244149-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | BLAQUIERE NICOLE (US) | 2012-09-27 | — | — | US | disclosed |
| US-8242104-B2 | Benzoxazepin P13K inhibitor compounds and methods of use | F. HOFFMAN-LA ROCHE AG (CH) | 2012-08-14 | — | — | US | disclosed |
| EP-2483278-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2012-08-08 | — | — | EP | disclosed |
| CN-102516117-A | Process for producing methyl hydrazine with hydrazine hydrate method | DONGLI NANTONG CHEMICALS CO LTD | 2012-06-27 | — | — | CN | disclosed |
| CN-102516117-A | Process for producing methyl hydrazine with hydrazine hydrate method | DONGLI NANTONG CHEMICALS CO LTD | 2012-06-27 | — | — | CN | disclosed |
| CN-102388044-A | Heterocyclic inhibitors of histamine receptors for the treatment of diseases | KALYPSYS INC | 2012-03-21 | — | — | CN | disclosed |
| US-20120065187-A1 | HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE | ALCON RESEARCH, LTD (US) | 2012-03-15 | — | — | US | disclosed |
| US-20110312940-A1 | TETRA-AZA-HETEROCYCLES AS PHOSPHATIDYLINOSITOL-3-KINASES (P13-KINASES) INHIBITOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-8057849-B2 | Ultra low melt metal nanoparticle composition for thick-film applications | XEROX CORPORATION (US) | 2011-11-15 | — | — | US | disclosed |
| US-20110257137-A1 | HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2011-10-20 | — | — | US | disclosed |
| EP-1645646-B1 | TEMPERATURE FUSE ELEMENT, TEMPERATURE FUSE AND BATTERY USING THE SAME | PANASONIC CORP (JP) | 2011-10-05 | — | — | EP | disclosed |
| WO-2011112731-A2 | HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20110135808-A1 | ULTRA LOW MELT METAL NANOPARTICLE COMPOSITION FOR THICK-FILM APPLICATIONS | XEROX CORPORATION (US) | 2011-06-09 | — | — | US | disclosed |
| CN-102087892-A | Ultra low melt metal nanoparticle composition and method of forming conductive features by using the same | XEROX CORP | 2011-06-08 | — | — | CN | disclosed |
| EP-2324029-A2 | HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE | Kalypsys, Inc. (US) | 2011-05-25 | — | — | EP | disclosed |
| CN-102009184-A | Method for preparing metal nanoparticles, composition thereof and process of forming metal frame | XEROX CORP | 2011-04-13 | — | — | CN | disclosed |
| WO-2011036280-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2011-03-31 | — | — | WO | disclosed |
| US-20110076292-A1 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2011-03-31 | — | — | US | disclosed |
| US-20110068889-A1 | THERMAL FUSE ELEMENT, THERMAL FUSE AND BATTERY USING THE THERMAL FUSE | SENDA KENJI | 2011-03-24 | — | — | US | disclosed |
| US-20110059233-A1 | Method For Preparing Stabilized Metal Nanoparticles | XEROX CORPORATION (US) | 2011-03-10 | — | — | US | disclosed |
| WO-2010123551-A1 | REGENERATION OF AMMONIA BORANE FROM POLYBORAZYLENE | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100272622-A1 | REGENERATION OF AMMONIA BORANE FROM POLYBORAZYLENE | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2010-10-28 | — | — | US | disclosed |
| CN-101815711-A | Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer | SCHERING CORP | 2010-08-25 | — | — | CN | disclosed |
| US-20100120741-A1 | HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
| CN-101027290-B | 2, 3-phthalazinone derivatives as AURORA-a kinase inhibitors | HOFFMANN LA ROCHE | 2010-05-12 | — | — | CN | disclosed |
| US-7683217-B2 | Process for preparing monomethylhydrazine | SALTIGO GMBH (DE) | 2010-03-23 | — | — | US | disclosed |
| WO-2010030785-A2 | HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE | KALYPSYS INC. (US) | 2010-03-18 | — | — | WO | disclosed |
| EP-2161087-A1 | Silver nanoparticle process | Xerox Corporation (US) | 2010-03-10 | — | — | EP | disclosed |
| EP-2155722-A1 | POLYCYCLIC INDAZOLE DERIVATIVES AND THEIR USE AS ERK INHIBITORS FOR THE TREATMENT OF CANCER | SCHERING CORPORATION (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2010015657-A2 | NEW ALKOXYPYRAZOLES | INSTITUT PASTEUR (FR) | 2010-02-11 | — | — | WO | disclosed |
| US-20100034693-A1 | SILVER NANOPARTICLE PROCESS | XEROX CORPORATION (US) | 2010-02-11 | — | — | US | disclosed |
| EP-2151433-A1 | Alkoxypyrazoles and the process for their preparation | Institut Pasteur (FR) | 2010-02-10 | — | — | EP | disclosed |
| CN-101643201-A | Silver nanoparticle process | XEROX CORP | 2010-02-10 | — | — | CN | disclosed |
| US-20090187045-A1 | PROCESS FOR PREPARING MONOMETHYLHYDRAZINE | SALTIGO GMBH (DE) | 2009-07-23 | — | — | US | disclosed |
| US-7563893-B2 | 3-Phenyl-cinnoline analogue and antitumor agent using the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-07-21 | — | — | US | disclosed |
| US-20090148600-A1 | Metal Nanoparticles Stabilized With a Carboxylic Acid-Organoamine Complex | XEROX CORPORATION (US) | 2009-06-11 | — | — | US | disclosed |
| CN-100497317-C | 3-phenyl-cinnoline homologue and antitumor agent containing the same | NIPPON KAYAKU KK (JP) | 2009-06-10 | — | — | CN | disclosed |
| CN-101450387-A | Metal nanoparticles stabilized with a carboxylic acid-organoamine complex | XEROX CORP (US) | 2009-06-10 | — | — | CN | disclosed |
| US-20090137575-A1 | Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents | SCHERING CORPORATION | 2009-05-28 | — | — | US | disclosed |
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MERCK SHARP & DOHME LLC | 2009-05-07 | — | — | US | disclosed |
| EP-1794148-B1 | NOVEL PHTHALAZINONE DERIVATIVES, AS AURORA-A KINASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2009-04-15 | — | — | EP | disclosed |
| EP-2042483-A1 | Method for manufacturing monomethyl hydrazine | Saltigo GmbH (DE) | 2009-04-01 | — | — | EP | disclosed |
| CN-101397264-A | Method for manufacturing monomethyl hydrazine | SALTIGO GMBH (DE) | 2009-04-01 | — | — | CN | disclosed |
| US-20090069288-A1 | Novel therapeutic compounds | ABBVIE INC. | 2009-03-12 | — | — | US | disclosed |
| US-7501410-B2 | Methods of inhibiting BTK and SYK protein kinases | ROCHE PALO ALTO LLC (US) | 2009-03-10 | — | — | US | disclosed |
| US-7494608-B2 | Stabilized silver nanoparticle composition | XEROX CORPORATION (US) | 2009-02-24 | — | — | US | disclosed |
| US-7482360-B2 | Fused tetracyclic mGluR1 antagonists as therapeutic agents | SCHERING CORPORATION (US) | 2009-01-27 | — | — | US | disclosed |
| CN-101351467-A | 3- (substituted amino) -pyrazolo [3, 4-d ] pyrimidines as EphB and VEGFR2 kinase inhibitors | NOVARTIS AG (CH) | 2009-01-21 | — | — | CN | disclosed |
| US-20080312218-A1 | FUSED TETRACYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS | SCHERING CORPORATION | 2008-12-18 | — | — | US | disclosed |
| WO-2008153858-A1 | POLYCYCLIC INDAZOLE DERIVATIVES AND THEIR USE AS ERK INHIBITORS FOR THE TREATMENT OF CANCER | SCHERING CORPORATION (US) | 2008-12-18 | — | — | WO | disclosed |
| EP-1998777-A1 | METHODS OF INHIBITING BTK AND SYK PROTEIN KINASES | F. Hoffmann-La Roche AG (CH) | 2008-12-10 | — | — | EP | disclosed |
| CN-101309925-A | Fused tetracyclic mglur1 antagonists as therapeutic agents | SCHERING CORP (US) | 2008-11-19 | — | — | CN | disclosed |
| US-20080275054-A1 | 3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors | HOLZER PHILIPP | 2008-11-06 | — | — | US | disclosed |
| EP-1633348-B1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2008-10-08 | — | — | EP | disclosed |
| US-7432379-B2 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| EP-1963327-A1 | 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS | Novartis AG (CH) | 2008-09-03 | — | — | EP | disclosed |
| US-7417152-B2 | 4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases | ELAN PHARMACEUTICALS, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| EP-1940850-A2 | FUSED TETRACYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS | SCHERING CORPORATION (US) | 2008-07-09 | — | — | EP | disclosed |
| CN-100376704-C | Temperature fuse element, temperature fuse and battery using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2008-03-26 | — | — | CN | disclosed |
| US-20080000382-A1 | STABILIZED SILVER NANOPARTICLE COMPOSITION | XEROX CORPORATION (US) | 2008-01-03 | — | — | US | disclosed |
| WO-2007107469-A1 | METHODS OF INHIBITING BTK AND SYK PROTEIN KINASES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-09-27 | — | — | WO | disclosed |
| US-20070219195-A1 | e.g. 4-(5-Methyl-2H-pyrazole-3-ylamino)-phenyl-2H-phthalazin-1-one2-Phenyl-2,3-dihydro-phthalazine-1,4-dione; tyrosine kinase inhibitor; antiinflammatory agent; asthma, rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis | ROCHE PALO ALTO LLC | 2007-09-20 | — | — | US | disclosed |
| US-7270694-B2 | Stabilized silver nanoparticles and their use | XEROX CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| CN-101027290-A | Novel 2,3-phthalazinone derivatives, as AURORA-A kinase inhibitors | HOFFMANN LA ROCHE (CH) | 2007-08-29 | — | — | CN | disclosed |
| EP-1794148-A1 | NOVEL PHTHALAZINONE DERIVATIVES, AS AURORA-A KINASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007062805-A1 | 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS | NOVARTIS AG (CH) | 2007-06-07 | — | — | WO | disclosed |
| US-7226923-B2 | Phthalazinone derivatives | HOFFMAN-LA ROCHE INC. (US) | 2007-06-05 | — | — | US | disclosed |
| US-20070099357-A1 | DEVICES CONTAINING ANNEALED STABILIZED SILVER NANOPARTICLES | XEROX CORPORATION (US) | 2007-05-03 | — | — | US | disclosed |
| WO-2007038209-A2 | FUSED TETRACYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS | SCHERING CORPORATION (US) | 2007-04-05 | — | — | WO | disclosed |
| US-20070024407-A1 | Temperature fuse element, temperature fuse and battery using the same | PANASONIC CORPORATION (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20060281733-A1 | 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases | ELAN PHARMACEUTICALS, INC. | 2006-12-14 | — | — | US | disclosed |
| CN-1863763-A | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion for the treatment of disease | JOLLA PHARMA (US) | 2006-11-15 | — | — | CN | disclosed |
| CN-1795280-A | Temperature fuse element, temperature fuse and battery using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2006-06-28 | — | — | CN | disclosed |
| EP-1663954-A2 | INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT OF DISEASES | LA JOLLA PHARMACEUTICAL CO. (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20060089359-A1 | Phthalazinone derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2006-04-27 | — | — | US | disclosed |
| EP-1184880-B1 | Conductive adhesive and packaging structure using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2006-04-19 | — | — | EP | disclosed |
| EP-1646095-A2 | Stabilised silver nanoparticles and their use | Xerox Corporation (US) | 2006-04-12 | — | — | EP | disclosed |
| EP-1645646-A1 | TEMPERATURE FUSE ELEMENT, TEMPERATURE FUSE AND BATTERY USING THE SAME | Matsushita Electric Industrial Co., Ltd. (JP) | 2006-04-12 | — | — | EP | disclosed |
| US-20060073667-A1 | Stabilized silver nanoparticles and their use | XEROX CORPORATION | 2006-04-06 | — | — | US | disclosed |
| WO-2006032518-A1 | NOVEL PHTHALAZINONE DERIVATIVES, AS AURORA-A KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-03-30 | — | — | WO | disclosed |
| CN-1247723-C | Conductive adhesive and assembled structural body by use of said adhesive | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2006-03-29 | — | — | CN | disclosed |
| US-20060058305-A1 | 3-Phenyl-cinnoline homologue and antitumor agent containing the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-03-16 | — | — | US | disclosed |
| CN-1735600-A | 3-phenyl-cinnoline homologue and antitumor agent containing the same | NIPPON KAYAKU KK (JP) | 2006-02-15 | — | — | CN | disclosed |
| EP-1571148-A1 | 3-PHENYL-CINNOLINE HOMOLOGUE AND ANTITUMOR AGENT CONTAINING THE SAME | Nippon Kayaku Kabushiki Kaisha (JP) | 2005-09-07 | — | — | EP | disclosed |
| WO-2005014530-A2 | INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT OF DISEASES | LA JOLLA PHARMACEUTICAL CO. (US) | 2005-02-17 | — | — | WO | disclosed |
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-01-27 | — | — | US | disclosed |
| US-6666994-B2 | Waterproof electrode; dispersion of conductivity particles in binder; contorlling corrosion | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20030116756-A1 | Conductive adhesive and packaging structure using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1061083-B1 | Adduct of a dialkylgalliumazide with hydrazine for MOCVD of GaN | KOREA RES INST CHEM TECH (KR) | 2003-04-02 | — | — | EP | disclosed |
| US-6524721-B2 | Binder resin, curing agent, and second metal particles that have a standard electrode potential lower than first metal particles | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-02-25 | — | — | US | disclosed |
| EP-1028116-B1 | Process for the production of taxol analogues 10-deacetyl taxol A, B, and C | COUNCIL SCIENT IND RES (IN) | 2002-10-02 | — | — | EP | disclosed |
| US-20020043652-A1 | Conductive adhesive and packaging structure using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. | 2002-04-18 | — | — | US | disclosed |
| CN-1340584-A | Conductive adhesive and assembled structural body by use of said adhesive | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2002-03-20 | — | — | CN | disclosed |
| EP-1184880-A2 | Conductive adhesive and packaging structure using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-03-06 | — | — | EP | disclosed |
| US-6329540-B1 | FOR METAL ORGANIC CHEMICAL VAPOR DEPOSITION (MOCVD) PROCESS FOR FORMING A GALLIUM NITRIDE FILM ON SUBSTRATES | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2001-12-11 | — | — | US | disclosed |
| US-6268315-B1 | Conditioning oil for bowling lanes | LANE MASTERS, INC. | 2001-07-31 | — | — | US | disclosed |
| CN-1290249-A | Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-04-04 | — | — | CN | disclosed |
| EP-1061083-A1 | Adduct of a dialkylgalliumazide with hydrazine for MOCVD of GaN | Korea Research Institute of Chemical Technology (KR) | 2000-12-20 | — | — | EP | disclosed |
| EP-1028116-A1 | Process for the production of taxol analogues 10-deacetyl taxol A, B, and C | Council of Scientific & Industrial Research (IN) | 2000-08-16 | — | — | EP | disclosed |
| US-6028206-A | IMPROVING THE CONVERSION OF THE TAXOL ANALOGUES 7-XYLOSYL-10-DEACETYL TAXOLS A,B,C INTO THE INTERMEDIATES 10-DEACETYL TAXOLS A,B,C; ANTITUMOR AGENTS TREATING CANCER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2000-02-22 | — | — | US | disclosed |
| EP-0779274-B1 | Process for the preparation of tertiary butyl hydrazine hydrohalogenide | JAPAN HYDRAZINE CO LTD (JP) | 1998-08-12 | — | — | EP | disclosed |
| US-5731465-A | Process for the preparation of tertiary butyl hydrazine hydrohalogenide | JAPAN HYDRAZINE CO., LTD. (JP) | 1998-03-24 | — | — | US | disclosed |
| EP-0518655-B1 | Solid phase peptide synthesis | ZENECA LTD (GB) | 1997-09-10 | — | — | EP | disclosed |
| EP-0779274-A1 | Process for the preparation of tertiary butyl hydrazine hydrohalogenide | JAPAN HYDRAZINE CO., LTD. (JP) | 1997-06-18 | — | — | EP | disclosed |
| EP-0758887-A1 | MULTIFUNCTIONAL LIGAND FOR USE AS A DIAGNOSTIC OR THERAPEUTIC PHARMACEUTICAL | CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5484940-A | ULTRAVIOLET RADIATION ABSORBERS FOR PLASTICS, AMYLOID PEPTIDE INHIBITORS, ALZHEIMER*S DISEASE | ATHENA NEUROSCIENCES, INC. | 1996-01-16 | — | — | US | disclosed |
| WO-1995029669-A2 | MULTIFUNCTIONAL LIGAND FOR USE AS A DIAGNOSTIC OR THERAPEUTIC PHARMACEUTICAL | CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1995-11-09 | — | — | WO | disclosed |
| EP-0518655-A2 | Solid phase peptide synthesis | ZENECA LIMITED (GB) | 1992-12-16 | — | — | EP | disclosed |
| JP-H0466291-A | CREAM SOLDER FOR PRINTING | UCHIHASHI ESTEC CO LTD | 1992-03-02 | — | — | JP | disclosed |
| EP-0167206-B1 | SYNTHETIC FRAIPONTITE AND PROCESS FOR PREPARATION THEREOF | MIZUSAWA INDUSTRIAL CHEMICALS LTD. (JP) | 1991-10-23 | — | — | EP | disclosed |
| CN-1011234-B | Improved synthesis method of difenzoquat | UNIV XIBEI (CN) | 1991-01-16 | — | — | CN | disclosed |
| US-4855501-A | Process for preparation of monomethylhydrazine | JAPAN HYDRAZINE CO., INC. (JP) | 1989-08-08 | — | — | US | disclosed |
| US-4855501-A | Process for preparation of monomethylhydrazine | JAPAN HYDRAZINE CO., INC. (JP) | 1989-08-08 | — | — | US | disclosed |
| CN-85108315-A | A kind of improved \" difenzoquat \" synthesis method | — | 1987-05-13 | — | — | CN | disclosed |
| US-4626420-A | WHITE DEVELOPER FOR LEUCO DYES | MIZUSAWA INDUSTRIAL CHEMICALS, LTD. (JP) | 1986-12-02 | — | — | US | disclosed |
| EP-0167206-A2 | Synthetic fraipontite and process for preparation thereof | MIZUSAWA INDUSTRIAL CHEMICALS LTD. (JP) | 1986-01-08 | — | — | EP | disclosed |
| JP-S58157751-A | RECOVERY OF MONOMETHYLHYDRAZINE | NIPPON HIDORAJIN KOGYO KK | 1983-09-19 | — | — | JP | disclosed |
| JP-S5798247-A | PREPARATION OF MONOMETHYLHYDRAZINE | NIPPON HIDORAJIN KOGYO KK | 1982-06-18 | — | — | JP | disclosed |
| US-4252958-A | ACETONE COMPOUND, AMMONIA DONER, HYDRAZINE HYDROHALIDE CATALYST | ARGUS CHEMICAL CORPORATION (US) | 1981-02-24 | — | — | US | disclosed |
| US-4219476-A | FREE RADICAL GENERATORS | PENNWALT CORPORATION (US) | 1980-08-26 | — | — | US | disclosed |
| US-4178444-A | Hydrazono derivatives of cephalosporins | CRAF SUD (IT) | 1979-12-11 | — | — | US | disclosed |
| US-4048423-A | Process for polymerizing unsaturated monomers and unsaturated polyester resins employing unsymmetrical tertiary-aliphatic azoalkanes | PENNWALT CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
| US-4008273-A | AZO INTERMEDIATE | PENNWALT CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-4007165-A | VINYL POLYMERIZATION INITIATORS POLYESTER CURING AGENTS | PENNWALT CORPORATION (US) | 1977-02-08 | — | — | US | disclosed |
| US-4001207-A | POLYESTER CURING AGENTS | PENNWALT CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-4001207-A | POLYESTER CURING AGENTS | PENNWALT CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |